Interventional device developer Boston Scientific has received clearance from the U.S. Food and Drug Administration (FDA) to market its FilterWire EZ embolic protection system for use in carotid artery stenting (CAS) procedures.
The device was cleared by the FDA in August 2004 for use in coronary saphenous vein graft interventions, and is a widely used embolic protection device for CAS procedures outside the U.S., according to the Natick, MA-based company.
By AuntMinnie.com staff writers
December 14, 2006
Related Reading
Boston Scientific, GE integrate informatics apps, November 9, 2006
Boston to bring Liberte to Japan, November 6, 2006
Boston Scientific supports STENT thrombosis study, October 24, 2006
Boston nets CE mark, October 16, 2006
Boston Scientific taps Japp, October 11, 2006
Copyright © 2006 AuntMinnie.com
